Provided by Tiger Fintech (Singapore) Pte. Ltd.

BridgeBio Pharma, Inc.

30.67
-0.7000-2.23%
Post-market: 30.820.1500+0.49%19:47 EDT
Volume:4.06M
Turnover:123.59M
Market Cap:5.83B
PE:-10.65
High:32.29
Open:29.52
Low:28.86
Close:31.37
Loading ...
Feb 26, 2021

Major Issues Report

8-K - Current report
Feb 25, 2021

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 17, 2021

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Feb 17, 2021

Major Issues Report

8-K - Current report
Feb 16, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 16, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 16, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 10, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 05, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Jan 29, 2021

Major Issues Report

8-K - Current report
Jan 26, 2021

Major Issues Report

8-K - Current report
Jan 26, 2021

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Jan 26, 2021

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Jan 26, 2021

Major Issues Report

8-K - Current report
Jan 25, 2021

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Jan 25, 2021

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Jan 20, 2021

Major Issues Report

8-K - Current report
Jan 13, 2021

Business Combinations

425 - Prospectuses and communications, business combinations
Jan 12, 2021

Major Issues Report

8-K - Current report
Jan 12, 2021

Business Combinations

425 - Prospectuses and communications, business combinations